Table 4.
TSH: OR (95 % CI), P | fT3: OR (95 % CI), P | fT4: OR (95 % CI), P | |
---|---|---|---|
Death in hospital or hospice | 0.635 (0.250–1.613), NS | 1.06 (0.569–1.974), NS | 1.957 (0.323–11.872), NS |
3 month outcome, mRS > 3 or death vs mRS < 2 | 0.686 (0.398–1.181), NS | 0.517 (0.226–1.185), NS | 1.574 (0.465–5.328), NS |
3 month outcome, mBI > 15 vs mBI < 14 or death | 0.707 (0.443–1.127), NS | 0.513 (.215–1.225), NS |
Multivariate regression results between thyroid hormones and acute and long-term outcomes post-stroke. When controlling for AFIB, depression, UTI, IA, age, and NIH on admission, thyroid markers were not associated with mortality or functional outcomes